Plain-English translation of NCT07607093 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study looks at whether treating an irregular heartbeat early — using medications, electrical therapy, or procedures — helps people who also have a leaky tricuspid valve (one of the heart's valves). The researchers want to understand if early treatment can prevent serious complications like heart failure, stroke, or the need for heart surgery later on.
When someone has both an irregular heartbeat and a leaky heart valve, these two problems can make each other worse over time, leading to heart failure and other serious complications. Right now, doctors don't know for certain whether treating the irregular heartbeat early in these patients actually makes a difference in their long-term health outcomes.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your existing medical records from 2013 to 2023 rather than asking you to visit a clinic or take new medications. They will compare outcomes between people who received early treatment for their irregular heartbeat and those who received standard care. No new treatments or procedures will be required as part of this study.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
South Korea
Enrollment target
~5,800 participants
Started
February 2026
Primary completion
February 2027
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ju Youn Kim, Ph.D
Samsung Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.